General

Showing 1425–1440 of 2270 results

Article: P.42 Acquired von Willebrand disease following marginal zone lymphoma relapse: a case report
€3.03 Add to cart
Article: P.42 Microvesicles bearing Tissue-Factor: a new potential biomarker for thrombosis in acute promyelocytic leukaemia
€3.03 Add to cart
Article: P.43 Alectinib-associated low grade hemolysis: unknown adverse reaction
€3.03 Add to cart
Article: P.43 Pneumatosis intestinalis as a sign of acute graft versus host disease. Pneumatosis intestinalis as a sign of acute graft versus host disease
€3.03 Add to cart
Article: P.44 Donor cell-derived acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation: molecular confirmation by next-generation sequencing
€3.03 Add to cart
Article: P.44 Localised leukaemic cerebral relapse following zygomycosis of the ear after chemotherapy consolidation for AML M1
€3.03 Add to cart
Article: P.45 Cerebrospinal fluid invasion in an APL patient. A case report
€3.03 Add to cart
Article: P.45 Development of a knowledge test on Immuno-T, a motion comic explaining immunotherapy to patients and their caregivers
€3.03 Add to cart
Article: P.46 Hepatitis E management in allogeneic Hematopoietic Stem Cell Transplant (HSCT) recipients: a case report
€3.03 Add to cart
Article: P.46 Purple skin lesions and low back pain
€3.03 Add to cart
Article: P.47 Impact of the oral and direct Factor Xa inhibitor Rivaroxaban on five routine coagulation assays, an in-vitro and ex-vivo study
€3.03 Add to cart
Article: P.49 Impact of thromboplastin’s choice on VKA treated patients monitoring
€3.03 Add to cart
Article: P.50 Rituximab as a maintenance treatment in thrombotic thrombocytopenic purpura : a case report
€3.03 Add to cart
Article: P.51 Relationship between thrombin generation and blood flow velocity in large cerebral arteries of children with sickle cell disease
€3.03 Add to cart
Article: P.52 Neuropeptides to replace serum in cryopreservation of mesenchymal stem cells?
€3.03 Add to cart
Article: P.52 Newborn screening for Sickle Cell Disease in Brussels, a program with an ongoing clinical outcome improvement
€3.03 Add to cart

Article: P.42 Acquired von Willebrand disease following marginal zone lymphoma relapse: a case report

Article: P.42 Microvesicles bearing Tissue-Factor: a new potential biomarker for thrombosis in acute promyelocytic leukaemia

Article: P.43 Alectinib-associated low grade hemolysis: unknown adverse reaction

Article: P.43 Pneumatosis intestinalis as a sign of acute graft versus host disease. Pneumatosis intestinalis as a sign of acute graft versus host disease

Article: P.44 Donor cell-derived acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation: molecular confirmation by next-generation sequencing

Article: P.44 Localised leukaemic cerebral relapse following zygomycosis of the ear after chemotherapy consolidation for AML M1

Article: P.45 Cerebrospinal fluid invasion in an APL patient. A case report

Article: P.45 Development of a knowledge test on Immuno-T, a motion comic explaining immunotherapy to patients and their caregivers

Article: P.46 Hepatitis E management in allogeneic Hematopoietic Stem Cell Transplant (HSCT) recipients: a case report

Article: P.46 Purple skin lesions and low back pain

Article: P.47 Impact of the oral and direct Factor Xa inhibitor Rivaroxaban on five routine coagulation assays, an in-vitro and ex-vivo study

Article: P.49 Impact of thromboplastin’s choice on VKA treated patients monitoring

Article: P.50 Rituximab as a maintenance treatment in thrombotic thrombocytopenic purpura : a case report

Article: P.51 Relationship between thrombin generation and blood flow velocity in large cerebral arteries of children with sickle cell disease

Article: P.52 Neuropeptides to replace serum in cryopreservation of mesenchymal stem cells?

Article: P.52 Newborn screening for Sickle Cell Disease in Brussels, a program with an ongoing clinical outcome improvement